AMP Celebrates Decision to Vacate FDA Rule on LDT Regs
A federal court ruled in favor of AMP, striking down the FDA’s attempt to regulate laboratory-developed tests (LDTs) as medical devices.
Read MorePosted by Chris Wolski | Jun 3, 2025 | Compliance |
A federal court ruled in favor of AMP, striking down the FDA’s attempt to regulate laboratory-developed tests (LDTs) as medical devices.
Read MorePosted by Chris Wolski | May 30, 2025 | POC Instruments |
Researchers have developed a new bioluminescence-based diagnostic tool that offers virus detection in complex biological samples.
Read MorePosted by Chris Wolski | May 28, 2025 | Infectious Diseases |
Rachel Burgoon developed a risk scoring tool to help physicians more effectively identify and treat drug-resistant infections.
Read MorePosted by Chris Wolski | May 15, 2025 | Compliance |
The ADLM has urged HHS to reinstate the CLIAC, warning that its elimination endangers test quality and patient care.
Read MorePosted by Chris Wolski | May 14, 2025 | Allergy & Autoimmune |
A new peer-reviewed study validates Vibrant Sciences’ microarray, enabling fast, accurate, scalable detection of over 17 tickborne pathogens.
Read More